Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Is Abbott Laboratories Still a Good Dividend Stock to Buy?: https://g.foolcdn.com/editorial/images/705508/smart-investor-looking-at-stock-charts-getty.jpg
Is Abbott Laboratories Still a Good Dividend Stock to Buy?

When it rains, it pours. After several weeks of relative quiet,  dividend-paying healthcare businesses are reporting quarterly results left and right. Unfortunately, not everyone is telling stories

2 Ultra-High-Yield Dividend Stocks You'll Regret Not Buying at These Prices: https://g.foolcdn.com/editorial/images/705382/22_08_08-a-piggy-bank-with-stacks-of-money-and-a-hand-putting-water-on-them-showing-growth-_mf-dload.jpg
2 Ultra-High-Yield Dividend Stocks You'll Regret Not Buying at These Prices

Incentives matter on Wall Street, and far too often the wrong incentives get insiders paid at the expense of investors. But sometimes you can find situations where the interests of shareholders and

Nasdaq Bear Market: 5 Terrific Growth Stocks You'll Regret Not Buying on the Dip: https://g.foolcdn.com/editorial/images/705111/bear-market-stocks-plunge-crash-invest-correction-getty.jpg
Nasdaq Bear Market: 5 Terrific Growth Stocks You'll Regret Not Buying on the Dip

There's a very good chance that when 2022 comes to a close, it'll be remembered as one of the most difficult years in history for professional and everyday investors. The first half of the year saw

Social Security Is About to Do Something It's Only Done 3 Times Before: https://g.foolcdn.com/editorial/images/705322/social-security-cards-6_gettyimages-184127461.jpg
Social Security Is About to Do Something It's Only Done 3 Times Before

Although Social Security has been around for a really long time, the program tends to evolve from year to year. One change seniors have come to expect is their annual cost-of-living adjustment, or

The Controversial Way Social Security Can Generate $775 Billion in Revenue Over the Next Decade: https://g.foolcdn.com/editorial/images/705670/social-security-card-with-cash-retirement-benefits-getty.jpg
The Controversial Way Social Security Can Generate $775 Billion in Revenue Over the Next Decade

For many Americans, Social Security already is, or will become, an important part of their monthly income during retirement. According to annual surveys conducted by Gallup over the past two

Why Novavax Stock Rose 12.57% on Friday: https://g.foolcdn.com/editorial/images/705802/biotech.jpg
Why Novavax Stock Rose 12.57% on Friday

Vaccine maker Novavax (NASDAQ: NVAX) saw its shares jump 12.57% on Friday. The stock closed at $17.18 on Thursday and opened at $17.27 on Friday. It climbed to as high as $19.46 before closing at

Hurricane Season Is Almost Over – In New Orleans And On Wall Street: https://www.valuewalk.com/wp-content/uploads/2017/02/Singleton-1.jpg
Hurricane Season Is Almost Over – In New Orleans And On Wall Street

For weekend reading, Gary Alexander, senior writer at Navellier & Associates, offers the following commentary:

The Hurricane Season Is Coming To An End

The official “hurricane season” runs six

Why Moderna Stock Rallied Today: https://g.foolcdn.com/editorial/images/705800/coronavirus-covid-19-vaccine-gettyimages-1347067432.jpg
Why Moderna Stock Rallied Today

Shares of Moderna (NASDAQ: MRNA) jumped 8.4% on Friday after rival drugmaker Pfizer (NYSE: PFE) said it intends to drastically increase the price of its COVID-19 vaccine next year.

Pfizer is seeking

My Top Industrial Stock to Buy in October: https://g.foolcdn.com/editorial/images/705346/22_10_19-two-people-in-a-hardware-store-shopping-for-power-tools-_mf-dload.jpg
My Top Industrial Stock to Buy in October

There are variations on the theme here, but one of the most provocative sayings on Wall Street is that you should buy when there's blood on the Street. That's definitely the case today with

Why Ally Financial Stock Dropped 10.2% This Week: https://g.foolcdn.com/editorial/images/705795/a-business-person-examining-data.jpg
Why Ally Financial Stock Dropped 10.2% This Week

Ally Financial (NYSE: ALLY) saw its stock price fall 10.2% this week on third-quarter earnings that did not meet analysts' expectations. The stock price stood at $29.25 per share at the market close

3 Top Stocks to Buy if There Is a Market Pull-back: https://g.foolcdn.com/editorial/images/705388/21_05_25-a-sign-with-the-word-dividends-next-to-a-money-roll-_gettyimages-186201544.jpg
3 Top Stocks to Buy if There Is a Market Pull-back

As the market pulls back in fits and starts, a normal pattern in a bear market, investors should have a wish list of companies that they want to buy at lower prices. Three good dividend names to

Why Meta Platforms, Roku, and Pinterest Stocks Crashed Friday Morning: https://g.foolcdn.com/editorial/images/705767/a-number-of-people-sitting-on-a-bench-and-smiling-while-looking-at-smartphones.jpg
Why Meta Platforms, Roku, and Pinterest Stocks Crashed Friday Morning

Snap (NYSE: SNAP) released disappointing financial results after the market close on Thursday, reporting that advertisers are reining in spending as a result of the rapidly deteriorating economic

Where Will Adobe Stock Be in 1 Year?: https://g.foolcdn.com/editorial/images/705502/two-designers-desktop.jpg
Where Will Adobe Stock Be in 1 Year?

Adobe's (NASDAQ: ADBE) stock rose slightly on Oct. 19 after the company revealed its guidance for fiscal 2023, which starts in early December. Let's review those new estimates and see if they'll

Why Tango Therapeutics Shares Rose 39.7% This Week: https://g.foolcdn.com/editorial/images/705786/gettyimages-1214328228-1.jpg
Why Tango Therapeutics Shares Rose 39.7% This Week

Shares of Tango Therapeutics (NASDAQ: TNGX), a biotech company that specializes in target cancer therapies, rose 39.7% this week, according to data from S&P Global Intelligence. The stock closed at

Is It Time To Snack On Mondelez Stock?: https://www.valuewalk.com/wp-content/uploads/2022/10/Mondelez.webp
Is It Time To Snack On Mondelez Stock?
  • Mondelez is the world’s #1 biscuit company and #2 chocolate maker
  • Snacks and candies are a durable business in both economic booms and recessions
  • The Clif Bar acquisition complements its snack
Why Schlumberger Led Energy Stocks Higher Today: https://g.foolcdn.com/editorial/images/705791/oil-derricks-in-the-desert.jpg
Why Schlumberger Led Energy Stocks Higher Today

Friday was a good day for the broad market, but a great one for oil and gas stocks. Schlumberger Limited (NYSE: SLB) ended today's session up 10.3% following an encouraging third-quarter earnings

Why Huntington Bancshares' Stock Rose Today: https://g.foolcdn.com/editorial/images/705782/generic-upward-11.jpg
Why Huntington Bancshares' Stock Rose Today

Shares of Huntington Bancshares (NASDAQ: HBAN) gained nearly 9.5% today after the large regional bank reported third-quarter earnings results.

Huntington reported earnings per common share of $0.39

Why We Need To Talk About Money And How To Get Started: https://www.valuewalk.com/wp-content/uploads/2017/02/Singleton-1.jpg
Why We Need To Talk About Money And How To Get Started

A few years ago, I was out on a hike with my friend when she asked me a question: “Are you on track to have enough money in your 401(k) by the time you are in your mid-50s to retire when you are

American Express Beats Earnings & Revenue Views, Raises Guidance: https://www.valuewalk.com/wp-content/uploads/2017/02/Singleton-1.jpg
American Express Beats Earnings & Revenue Views, Raises Guidance
  • American Express profit came in at $2.47 per share, ahead of expectations for $2.40 per share. Revenue was $13.6 billion, also beating views.
  • The company cited growth in goods and services
1 Eye-Popping Figure EV investors Need to See: https://g.foolcdn.com/editorial/images/705265/f-150_lightning_platinum_on-road_04.jpg
1 Eye-Popping Figure EV investors Need to See

The move to electric vehicles (EV) has been happening slowly for many reasons. One of the points of friction has been the lack of charging infrastructure. But there's one eye-popping number and a

1 Growth Stock Down 78% That Could Drop Further: Here's Why It's a Buy Anyway: https://g.foolcdn.com/editorial/images/705400/person-working-at-a-desk.jpg
1 Growth Stock Down 78% That Could Drop Further: Here's Why It's a Buy Anyway

The market is still experiencing a downturn. When will it bottom out? It's nearly impossible to predict. Moreover, investors shouldn't focus on trying to time the market. Although stocks might fall

This Growth Stock Just Hit a New 52-Week High and Still Has Room to Grow: https://g.foolcdn.com/editorial/images/705321/lipstick-cosmetics-beauty-care-products-getty.jpeg
This Growth Stock Just Hit a New 52-Week High and Still Has Room to Grow

The economy has all the earmarks of heading toward recession, and the stock market indices that had been going up in recent days are turning down once more. Both the S&P 500 and Nasdaq Composite

Snap Stock Falls As User Growth Slows To Single-Digits: https://www.valuewalk.com/wp-content/uploads/2017/02/Singleton-1.jpg
Snap Stock Falls As User Growth Slows To Single-Digits
  • Snap’s third quarter revenue came in at $1.13 billion, compared to 1.14 billion projected.
  • Daily Active Users (DAU) increased to 363 million.
  • Snap continues to struggle as restructuring costs, and
Why Verizon Stock Dropped Today: https://g.foolcdn.com/editorial/images/705789/investor-gettyimages-1151342851.jpg
Why Verizon Stock Dropped Today

Shares of Verizon (NYSE: VZ) fell 4.5% on Friday, as investors grew increasingly concerned about the wireless giant's waning customer growth.

Verizon's revenue rose 4% year over year to $34.2

Dark Day For Talaris Therapeutics Sees The Stock Dive 44% After Trial Patient Fatality: https://www.valuewalk.com/wp-content/uploads/2017/02/Singleton-1.jpg
Dark Day For Talaris Therapeutics Sees The Stock Dive 44% After Trial Patient Fatality

Discusses the event and how it unfolded with market commentary

It was a dark day of trading on Thursday for biopharma Talaris Therapeutics Inc  (NASDAQ:TALS) after management reported a fatality of